Max Kates
Johns Hopkins University
H-index: 34
North America-United States
Top articles of Max Kates
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Tumour tissue‐derived small extracellular vesicles reflect molecular subtypes of bladder cancer | Journal of Extracellular Vesicles | Liang Dong Mingxiao Feng Morgan D Kuczler Kengo Horie Chi‐Ju Kim | 2024/2 |
Racial Differences in the Detection Rate of Bladder Cancer Using Blue Light Cystoscopy: Insights from a Multicenter Registry | Cancers | Seyedeh-Sanam Ladi-Seyedian Alireza Ghoreifi Badrinath Konety Kamal Pohar Jeffrey M Holzbeierlein | 2024/3/24 |
PD48-01 EFFICACY OF NADOFARAGENE FIRADENOVEC-VNCG FOR PATIENTS WITH BACILLUS CALMETTE-GUÉRIN-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER: FINAL RESULTS FROM A PHASE 3 TRIAL | The Journal of Urology | Stephen A Boorjian Vikram M Narayan Badrinath R Konety Viraj A Master Neal D Shore | 2024/5 |
MP71-02 WHAT WILL IT TAKE TO REPLACE SURVEILLANCE CYSTOSCOPY WITH URINE BIOMARKER X? A MONTE-CARLO SIMULATION | The Journal of Urology | Zhuo T Su James Flynn Aurora Grutman Royce Lee Katherine Mahon | 2024/5 |
Urinary IL‐6 and IL‐8 as predictive markers in bladder urothelial carcinoma: A pilot study | Cancer Cytopathology | Christopher J VandenBussche Christopher D Heaney Max Kates John J Hooks Kelly Baloga | 2024/1 |
Efficacy of intravesical nadofaragene firadenovec-vncg for patients with Bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer: 36-month follow-up from a … | Urologic Oncology: Seminars and Original Investigations | Stephen A Boorjian Vikram M Narayan Viraj A Master Badrinath R Konety Neal D Shore | 2024/3/1 |
A Phase II Trial of Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guérin‒Naïve Nonmuscle-Invasive Urothelial Carcinoma of the Bladder | The Journal of Urology | Sunil H Patel Andrew T Gabrielson Sin Chan Deborah Schwartz Connie Collins | 2024/4/23 |
MP57-10 BENEFITS AND COSTS OF ALTERNATIVE GUIDELINES FOR SURVEILLANCE OF LOW-GRADE (LG) NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) | The Journal of Urology | Zhuo T Su Katherine Mahon Michael Rezaee Sunil Patel Jeffrey Townsend | 2024/5 |
ASSESSING THE CLINICAL IMPACT AND COSTS OF INCISIONAL NEGATIVE PRESSURE WOUND THERAPY FOR PREVENTING SURGICAL WOUND COMPLICATIONS AFTER RADICAL CYSTECTOMY | Urologic Oncology: Seminars and Original Investigations | Katherine Rodriguez-Mahon Max Kates Zhuo Tony Su Isabella Florissi Michael Rezaee | 2024/3/1 |
Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712 | European Urology Oncology | Zaker Rana Sophia C Kamran Amol C Shetty Philip Sutera Yang Song | 2024/4/18 |
MP16-14 A PHASE II TRIAL OF INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG-NAÏVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER | The Journal of Urology | Sunil H Patel Andrew T Gabrielson Sin Chan Deborah Schwartz Connie Collins | 2024/5 |
PRE-CYSTECTOMY MAGNETIC RESONANCE IMAGING WITH SPECIFIC BLADDER PROTOCOL: DIAGNOSTIC UTILITY AND COMPARISON TO FINAL SURGICAL PATHOLOGY | Urologic Oncology: Seminars and Original Investigations | Katherine Rodriguez-Mahon Max Kates Zhuo Tony Su Royce Lee Michael Rezaee | 2024/3/1 |
Interruptions in bladder cancer care during the COVID-19 public health emergency | Urologic Oncology: Seminars and Original Investigations | John L Gore Kristin Follmer Jason Reynolds Michael Nash Christopher B Anderson | 2024/4/1 |
MP71-20 BENEFITS AND COSTS OF ALTERNATIVE GUIDELINES FOR SURVEILLANCE OF HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) | The Journal of Urology | Zhuo T Su Katherine Mahon Michael Rezaee Sunil Patel Jeffrey Townsend | 2024/5 |
MP38-15 WHAT WILL IT TAKE FOR A URINE BIOMARKER TO REPLACE SURVEILLANCE CYSTOSCOPY FOR INTRAVESICAL RECURRENCE (IVR) AFTER RADICAL NEPHROURETERECTOMY (RNU) | The Journal of Urology | Zhuo T Su Royce Lee Aurora Grutman James Flynn Joseph Cheaib | 2024/5 |
ERAS FOR AMBULATORY TURBT: ENHANCING BLADDER CANCER CARE (EMBRACE) RANDOMIZED CONTROLLED TRIAL | Urologic Oncology: Seminars and Original Investigations | Michael E Rezaee Katherine Rodriguez-Mahon Bruce J Trock The-Hung Edward Nguyen Armine K Smith | 2024/3/1 |
Reply to Kentaro Inamura's Letter to the Editor re: Mingxiao Feng, Andres Matoso, Gabriel Epstein, et al. Identification of Lineage-specific Transcriptional Factor-defined … | European urology | Mingxiao Feng Andres Matoso Gabriel Epstein Megan Fong Yong Hyun Park | 2024/4 |
PD37-01 MEASURING SEMINIFEROUS TUBULES DIAMETER USING HIGH-FREQUENCY ULTRASOUND IN MURINE MODELS AND MEN WITH NON-OBSTRUCTIVE AZOOSPERMIA AND OBSTRUCTIVE AZOOSPERMIA | The Journal of Urology | Taylor P Kohn Nora Haney Amin Herati Max Kates Kenneth Pienta | 2024/5 |
MP55-20 THE EFFECT OF NEONATAL UPPER AND LOWER URINARY TRACT OBSTRUCTION ON THE GASTROINTESTINAL MICROBIOME IN a MURINE ANIMAL MODEL | The Journal of Urology | Nora M Haney Kara Lombardo Taylor P Kohn Charlotte Q Wu Max R Kates | 2024/5 |
A first-in-human trial of intravesical enfortumab vedotin (EV), an antibody-drug conjugate (ADC), in patients with non-muscle invasive bladder cancer (NMIBC): Interim results … | Ashish M Kamat Yair Lotan Morgan Roupret Gary D Steinberg Brant A Inman | 2023/6/1 |
